These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38570378)

  • 1. Changes in the Urinary Microbiome After Transurethral Resection of Non-muscle-Invasive Bladder Cancer: Insights from a Prospective Observational Study.
    Ślusarczyk A; Ismail H; Zapała Ł; Piecha T; Zapała P; Radziszewski P
    Ann Surg Oncol; 2024 Jul; 31(7):4773-4786. PubMed ID: 38570378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance and predictive capacity of early urine cytology after transurethral resection of nonmuscle invasive bladder cancer: A prospective study.
    Elsawy AA; Harraz AM; Ghobrial FK; Abdullatef M; Ali-El-Dein B
    Urol Oncol; 2020 Dec; 38(12):935.e1-935.e8. PubMed ID: 32654947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in Urobiome in Patients With Bladder Cancer and Implications for Clinical Outcome: A Single-Institution Study.
    Zeng J; Zhang G; Chen C; Li K; Wen Y; Zhao J; Wu P
    Front Cell Infect Microbiol; 2020; 10():555508. PubMed ID: 33384966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the association between the urinary microbiome and bladder cancer: An exploratory study.
    Hussein AA; Elsayed AS; Durrani M; Jing Z; Iqbal U; Gomez EC; Singh PK; Liu S; Smith G; Tang L; Guru KA
    Urol Oncol; 2021 Jun; 39(6):370.e9-370.e19. PubMed ID: 33436328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
    Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
    Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM;
    BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme.
    Mariappan P; Johnston A; Padovani L; Clark E; Trail M; Hamid S; Hollins G; Simpson H; Thomas BG; Hasan R; Bhatt J; Ahmad I; Nandwani GM; Mitchell IDC; Hendry D;
    Eur Urol; 2020 Oct; 78(4):520-530. PubMed ID: 32690321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study).
    Miyake M; Nishimura N; Inoue T; Suzuki S; Fujii T; Owari T; Hori S; Nakai Y; Toritsuka M; Nakagawa H; Tsukamoto S; Anai S; Torimoto K; Yoneda T; Tanaka N; Fujimoto K
    Trials; 2021 Feb; 22(1):136. PubMed ID: 33579327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of the COVID19 pandemic on the need and timing of second transurethral bladder tumour resection in high-grade non-muscle invasive bladder cancer.
    Vanneste M; van der Heij B; Christiaansen CE; Berendsen CL; Driessen EJM; Bruins HM
    World J Urol; 2023 Aug; 41(8):2173-2178. PubMed ID: 37328699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Risk Factors for Recurrence after Transurethral Resection of Bladder Tumor in Patients with Non-Muscle Invasive Bladder Cancer: 2-Year Follow-Up Outcomes.
    Li H; Wang L; Li H; Zhang P; Li Z; Xue L; Wang Z; Fu D; Chen Q; Luo Q; Chong T; Wang Z
    Oncology; 2024; 102(4):337-342. PubMed ID: 37647883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-life Experience: Early Recurrence With Hexvix Photodynamic Diagnosis-assisted Transurethral Resection of Bladder Tumour vs Good-quality White Light TURBT in New Non-muscle-invasive Bladder Cancer.
    Mariappan P; Rai B; El-Mokadem I; Anderson CH; Lee H; Stewart S; Donat R
    Urology; 2015 Aug; 86(2):327-31. PubMed ID: 26142924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China.
    Wu P; Zhang G; Zhao J; Chen J; Chen Y; Huang W; Zhong J; Zeng J
    Front Cell Infect Microbiol; 2018; 8():167. PubMed ID: 29904624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients.
    Pederzoli F; Ferrarese R; Amato V; Locatelli I; Alchera E; Lucianò R; Nebuloni M; Briganti A; Gallina A; Colombo R; Necchi A; Clementi M; Montorsi F; Mancini N; Salonia A; Alfano M
    Eur Urol Oncol; 2020 Dec; 3(6):784-788. PubMed ID: 32345542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer.
    Tae BS; Jeong CW; Kwak C; Kim HH; Moon KC; Ku JH
    PLoS One; 2017; 12(12):e0189354. PubMed ID: 29244843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the urinary microbiome profile change after treatment of bladder cancer?
    Hussein AA; Bhat TA; Jing Z; Gomez EC; Wasay MA; Singh PK; Liu S; Smith G; Guru KA
    World J Urol; 2023 Dec; 41(12):3593-3598. PubMed ID: 37796319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Microbiome of Catheter Collected Urine in Males with Bladder Cancer According to Disease Stage.
    Oresta B; Braga D; Lazzeri M; Frego N; Saita A; Faccani C; Fasulo V; Colombo P; Guazzoni G; Hurle R; Rescigno M
    J Urol; 2021 Jan; 205(1):86-93. PubMed ID: 32856979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between urine cytology results on the day after overnight continuous saline irrigation following transurethral resection of bladder tumor and bladder tumor recurrence.
    Kim DH; Choi MS; Choi JH; Lee C; Jeh SU; Kam SC; Hwa JS; Hyun JS; Choi SM
    Investig Clin Urol; 2024 May; 65(3):279-285. PubMed ID: 38714518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact on Japanese healthcare economics of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer: A multicenter retrospective cohort study.
    Nishimura N; Miyake M; Nakahama T; Miyamoto T; Nishimoto K; Oyama M; Matsushita Y; Miyake H; Fukuhara H; Inoue K; Kobayashi K; Matsumoto H; Matsuyama H; Fujii T; Hirao Y; Fujimoto K
    Int J Urol; 2023 Dec; 30(12):1112-1119. PubMed ID: 37605814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EFFICACY OF DIFFERENT RESECTIONS ON NON-MUSCLE-INVASIVE BLADDER CANCER AND ANALYSIS OF THE OPTIMAL SURGICAL METHOD.
    Chen GF; Shi TP; Wang BJ; Wang XY; Zang Q
    J Biol Regul Homeost Agents; 2015; 29(2):465-70. PubMed ID: 26122238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.